Magrath George 4

What Happened George Magrath, CEO of Opus Genetics, was granted 483,639 restricted stock units (RSUs) on January 22, 2026. The award was granted at $0.00 per share (typical for RSUs), so no cash was paid; the reported dollar value at grant is $0. This is a compensation grant (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-01-22; Form 4 filed: 2026-01-26 (filed within the standard 2-business-day window).
• Grant amount: 483,639 RSUs at $0.00 per share (no cash exchanged).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The RSUs "vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters," subject to Magrath's continued service.

Context RSUs are a common form of equity compensation that convert into actual shares only as they vest; they are not an immediate purchase and do not by themselves indicate buying or selling sentiment. This award appears to be a multi-year retention/compensation grant (vesting over ~4 years).